6 September 2023 - NICE has published final evidence-based recommendations on the use of mavacamten (Camzyos) for the treatment of ...
5 September 2023 - On 26 July 2023, the World Health Organization published the 23rd edition of its essential medicines list.1 ...
4 September 2023 - NICE has recommended Chiesi’s Elfabrio (pegunigalsidase alfa) as a long-term option for treating Fabry disease in ...
1 September 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
24 August 2023 - The international collaboration between six health technology assessment bodies from across the UK, Australia and Canada has ...
23 August 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
18 August 2023 - Around 670 people in England with painful and debilitating skin wounds caused by a rare inherited disorder ...
17 August 2023 - The UK's cost effectiveness agency NICE has recommended MSD's PD-1 inhibitor Keytruda for a series of ...
15 August 2023 - NICE has published evidence-based recommendations on the use of cipaglucosidase alfa (Pombiliti) with miglustat (Opfolda) for ...
1 August 2023 - Local GP leaders across the south of England have told practices not to follow the NHS’s ...
3 August 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
2 August 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
2 August 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
1 August 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
28 July 2023 - NICE has published preliminary evidence-based recommendations on the use of talazoparib tosylate (Talzenna) for the treatment of ...